{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:42:54Z","timestamp":1758127374348},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,2,21]],"date-time":"2003-02-21T00:00:00Z","timestamp":1045785600000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aim.<\/jats:bold> We tested whether serial 20\u00a0MHz endosonography (EUS) and anti\u2010<jats:italic>Helicobacter\u00a0pylori<\/jats:italic> immunoblots can predict the complete regression of gastric MALToma by <jats:italic>H.\u00a0pylori<\/jats:italic> eradication.<\/jats:p><jats:p><jats:bold>Methods.<\/jats:bold> The serums of 17 MALToma patients, including 15 with low grade and two with high grade, were collected before therapy. Fifteen patients with low\u2010grade MALToma and 18 nonMALToma patients, all infected with <jats:italic>H.\u00a0pylori<\/jats:italic>, have been followed with serum sampling, endoscopy, and EUS on enrollment, on the 2nd, 6th, and 12th months after anti\u2010<jats:italic>H.\u00a0pylori<\/jats:italic> therapy. All sera were tested for anti\u2010<jats:italic>H.\u00a0pylori<\/jats:italic> immunoblots, including 19.5, 26.5, 30, 35, 89, 116 KDa (CagA), FldA. The DNAs were extracted serially from the biopsy of MALToma patients before and after therapy to perform polymerase chain reaction (PCR) for the immunoglobulin heavy\u2010chain gene monoclonality.<\/jats:p><jats:p><jats:bold>Results.<\/jats:bold> MALToma patients had higher prevalence rates of anti\u2010FldA protein, 19.5 and 30\u00a0KDa antibodies of <jats:italic>H.\u00a0pylori<\/jats:italic> (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.01). After <jats:italic>H.\u00a0pylori<\/jats:italic> eradication, MALToma patients had negative seroconversion of 19.5, 26.5, 30, and 35 KDa antibodies (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05), but not in CagA and FldA. The PCR monoclonality occurred in 80% (12\/15) of the MALToma patients before therapy, but did not correlate with any seroconversion of anti\u2010<jats:italic>H.\u00a0pylori<\/jats:italic> immunoblots after therapy (<jats:italic>p<\/jats:italic>\u00a0&gt;\u00a00.05). Complete regression of MALToma was observed in 73.3% (11\/15) of patients. Evaluation with 20\u00a0MHz EUS, for the initial tumor depth and its normalization on the 6th month had 90.9% sensitivity and 100% specificity to predict the complete regression.<\/jats:p><jats:p><jats:bold>Discussion.<\/jats:bold> The negative seroconversions of the smaller\u2010molecular\u2010weight proteins, but not CagA and FldA, correlate with regression of MALToma by <jats:italic>H.\u00a0pylori<\/jats:italic> eradication. 20\u00a0MHz EUS can effectively predict the therapeutic response of MALToma.<\/jats:p>","DOI":"10.1046\/j.1523-5378.2003.00122.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:23:32Z","timestamp":1047425012000},"page":"36-45","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Application of 20\u00a0MHz Endosonography and Anti\u2010<i>Helicobacter pylori<\/i> Immunoblots to Predict Regression of Low\u2010grade Gastric MALToma by <i>H. pylori<\/i> Eradication"],"prefix":"10.1111","volume":"8","author":[{"given":"Bor\u2010Shyang","family":"Sheu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu\u2010Chu","family":"Shiesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Town","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao\u2010Bai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih\u2010Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn\u2010Jong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,2,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70575-5"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70483-X"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.agast971131810a"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91408-E"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709000208"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70553-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70028-3"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008209"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70196-X"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/106.5.670"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322502"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(97)70120-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood.V85.3.857.bloodjournal853857","article-title":"Lymphoma classification proposal: clarification","volume":"85","author":"Harris NL","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199600001-00002"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70026-X"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V87.4.1255.bloodjournal8741255","article-title":"Diagnostic and post\u2010treatment follow\u2010up of Helicobacter pylori\u2010positive gastric lymphoma of mucosa\u2010associated lymphoid tissue: histology, polymerase chain reaction or both","volume":"87","author":"Savio A","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005460130305"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.6.1600"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80014-5"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.3.297"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.4.454"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.2003.00122.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T14:58:16Z","timestamp":1697209096000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1523-5378.2003.00122.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1046\/j.1523-5378.2003.00122.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-5378.2003.00122.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}